Prevalence of liver steatosis in patients with chronic hepatitis B: A study of associated factors and of relationship with fibrosis

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 3, 2006, Pages 233-237

  Thomopoulos, Konstantinos C ^a,b   Arvaniti, Vassiliki ^a   Tsamantas, Athanasios C ^a   Dimitropoulou, Dimitra ^a   Gogos, Charalambos A ^a   Siagris, Dimitrios ^a   Theocharis, George J ^a   Labropoulou Karatza, Chryssoula ^a  

^a UNIVERSITY HOSPITAL OF PATRAS   (Greece)

^b UNIVERSITY OF PATRAS   (Greece)

Author keywords

Chronic hepatitis B; Fibrosis; Steatosis

Indexed keywords

GLUCOSE; HEPATITIS B(E) ANTIGEN;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC HEPATITIS; CORRELATION ANALYSIS; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; GLUCOSE BLOOD LEVEL; HEPATITIS B; HUMAN; HUMAN TISSUE; INFLAMMATION; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; OBESITY; PARAMETER; PATIENT; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; AGED; BLOOD GLUCOSE; FATTY LIVER; FEMALE; FIBROSIS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; LIVER; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NECROSIS; OVERWEIGHT; PREVALENCE; RETROSPECTIVE STUDIES;

EID: 33644593865     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200603000-00002     Document Type: Article

References (26)

1. Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors. Hepatology 1990; 12:1106-1110.
2. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231.
3. Lonardo A, Adinolfi LE, Loria P, Carulli N, Ruggiero G, Day CP. Steatosis and hepatitis C virus: mechanisms and significance for hepatic and extrahepatic disease. Gastroenterology 2004; 126:586-597.
4. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Host- and disease-specific factors affecting steatosis in chronic hepatitis C. J Hepatol 1998; 29:198-206.
5. Hwang SJ, Luo JC, Chu CW, Lai CR, Lu CL, Tsay SH, et al. Hepatic steatosis in chronic hepatitis C virus infection: prevalence and clinical correlation. J Gastroenterol Hepatol 2001; 16:190-195.
6. Fiore G, Fera G, Napoli N, Vella F, Schiraldi O. Liver steatosis and chronic hepatitis C: a spurious association? Eur J Gastroenterol Hepatol 1996; 8:125-129.
7. Hu KQ, Kyulo NL, Esrailian E, Thompson K, Chase R, Hillebrand DJ, Runyon BA. Overweight and obesity, hepatic steatosis, and progression of chronic hepatitis C: a retrospective study on a large cohort of patients in the United States. J Hepatol 2004; 40:147-154.
8. Powell EE, Johnsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005; 42:5-13.
9. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 2001; 33:1358-1364.
10. Westin J, Nordlinder H, Lagging M, Norkrans G, Wejstal R. Steatosis accelerates fibrosis development over time in hepatitis C virus genotype 3 infected patients. J Hepatol 2002; 37:837-842.
11. Lefkowitch JH, Schiff ER, Davis GL, Perrillo RP, Lindsay K, Bodenheimer HC Jr, et al. Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. Gastroenterology 1993; 104:595-603.
12. Gordon A, McLean C, Pedersen J, Bailey M, Roberts S. Hepatic steatosis in chronic hepatitis B and C: predictors, distribution and effect on fibrosis. J Hepatol 2005; 43:38-44.
13. Fabris P, Floreani A, Carlotto A, Giordani MT, Baldo V, Stecca C, et al. Alcohol is an important co-factor for both steatosis and fibrosis in Northern Italian patients with chronic hepatitis C. J Hepatol 2004; 41:644-651.
14. Naveau S, Giraud V, Borotto E, Aubert A, Capron F, Chaput JC. Excess weight risk factor for alcoholic liver disease. Hepatology 1997; 25:108-111.
15. Castera L, Chouteau P, Hezode C, Zafrani ES, Dhumeaux D, Pawlotsky JM. Hepatitis C virus-induced hepatocellular steatosis. Am J Gastroenterol 2005; 100:711-715.
16. Meek SE, Nair KS, Jensen MD. Insulin regulation of regional free fatty acid metabolism. Diabetes 1999; 48:10-14.
17. Berson A, De Beco V, Letteron P, Robin MA, Moreau C, El Kahwaji J, et al. Steatohepatitis-inducing drugs cause mitochondrial dysfunction and lipid peroxidation in rat hepatocytes B. Gastroenterology 1998; 114:764-774.
18. Farinati F, Cardin R, de Maria N, Lecis PE, Delia Libera G, Burra P, et al. Zinc, iron, and peroxidation in liver tissue. Cumulative effects of alcohol consumption and virus-mediated damage - a preliminary report. Biol Trace Elem Res 1995; 47:193-199.
19. Lee KS, Buck M, Houglum K, Chojkier M, Lee KS, Buck M, Houglum K. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J Clin Invest 1995; 96:2461-2468.
20. Altlparmak E, Köklü S, Yallnklllc M, Yüksel M, Cicek C, Kayacetin E, et al. Viral and host causes of fatty liver in chronic hepatitis B. World J Gastroenterol 2005; 11:3056-3059.
21. Ong JP, Younossi ZM, Speer C, Olano A, Gramlich T, Boparai N. Chronic hepatitis C and superimposed nonalcoholic fatty liver disease. Liver 2001; 21:266-271.
22. Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallee M, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 2004; 40:484-490.
23. Asselah T, Boyer N, Guimont MC, Cazals-Hatem D, Tubach F, Nahon K, et al. Liver fibrosis is not associated with steatosis but with necroinflammation in French patients with chronic hepatitis C. Gut 2003; 52:1638-1643.
24. Lok AS, Everhart JE, Wright E, Chung R, Greenson JK. Steatosis is common in advanced hepatitis C and related to BMI, hypertriglyceridemia and genotype 3. Hepatology 2003; 38 (suppl):574A.
25. Thomopoulos KC, Theocharis GJ, Tsamantas AC, Siagris D, Dimitropoulou D, Gogos CA, Labropoulou-Karatza C. Liver steatosis is an independent risk factor for treatment failure in patients with chronic hepatitis C. Eur J Gastroenterol Hepatol 2005; 17:149-153.
26. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol. Hepatology 2002; 36:729-736.